Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Colorectal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)UnknownNCT00513266
What this trial is testing

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Centre Hospitalier Universitaire Vaudois 35
Early research (Phase 1)Looking for participantsNCT05611034
What this trial is testing

In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung

Who this might be right for
Lung MetastasesColorectal Cancer MetastaticColorectal Cancer
University Health Network, Toronto 10
Not applicableStudy completedNCT01751516
What this trial is testing

PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study

Who this might be right for
Rectal Carcinoma
UNC Lineberger Comprehensive Cancer Center 8
Not applicableStudy completedNCT04926376
What this trial is testing

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer
ABK Biomedical 8
Not applicableEnded earlyNCT01266187
What this trial is testing

Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study)

Who this might be right for
Liver Metastasis
RWTH Aachen University 16
Not applicableEnded earlyNCT02866344
What this trial is testing

Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisHepatic Neoplasms
Wake Forest University Health Sciences 1
Large-scale testing (Phase 3)Ended earlyNCT01842971
What this trial is testing

ALPPS (Liver Partition and Portal Vein Ligation) for Two-stage Hepatectomy for Colorectal Liver Metastasis

Who this might be right for
Colorectal Cancer
Centre Hospitalier Universitaire, Amiens 3
Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Testing effectiveness (Phase 2)Study completedNCT01053013
What this trial is testing

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectablePancreatic Adenocarcinoma MetastaticColorectal Cancer Metastatic
The Rogosin Institute 58
Testing effectiveness (Phase 2)UnknownNCT05371197
What this trial is testing

Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer

Who this might be right for
Colorectal CancerMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)+1 more
Third Affiliated Hospital, Sun Yat-Sen University 26
Large-scale testing (Phase 3)UnknownNCT02350166
What this trial is testing

Short-term Effects of LASI Surgery Versus Conventional Laparotomy for Colorectal Liver Metastasis

Who this might be right for
Colorectal Cancer
West China Hospital 40
Large-scale testing (Phase 3)UnknownNCT01035385
What this trial is testing

Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)

Who this might be right for
Colorectal CancerLiver Metastasis
Guangdong Provincial People's Hospital 340
Testing effectiveness (Phase 2)Looking for participantsNCT06605430
What this trial is testing

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

Who this might be right for
Pancreatic Cancer Non-resectablePancreatic Cancer MetastaticColorectal Cancer Metastatic
HealthPartners Institute 64
Not applicableStudy completedNCT01343901
What this trial is testing

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 210
Early research (Phase 1)Study completedNCT00059930
What this trial is testing

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 38
Large-scale testing (Phase 3)UnknownNCT00630045
What this trial is testing

Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis

Who this might be right for
Colorectal CancerResectable Liver Metastasis
Peking University People's Hospital 392
Testing effectiveness (Phase 2)UnknownNCT00438737
What this trial is testing

Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 100
Testing effectiveness (Phase 2)UnknownNCT00594529
What this trial is testing

Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers

Who this might be right for
Colorectal CancerLiver Metastasis
Kyoto University 27
Large-scale testing (Phase 3)Looking for participantsNCT06280495
What this trial is testing

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

Who this might be right for
Colorectal CancerLiver Metastases
Sun Yat-sen University 156
Next Page